$3 billion FUJIFILM deal will nearly double Regeneron’s large-scale U.S. biologics manufacturing capacity over the next decade. Regeneron adds 7,000+ U.S. jobs in five years, with $7B+ in ...

“Regeneron is an American success story, with over 80 percent of our workforce and assets in the U.S. and all of our FDA-approved medicines invented in our New York laboratories. Our innovative ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

Regeneron Pharmaceuticals, Inc.'s stock has dropped 30% since July due to concerns around Eylea's declining market share in the face of competition from generics and Roche's Vabysmo. Dupixent's ...

Regeneron showcases robust product sales growth amidst competitive pharmaceutical landscape. Strategic collaborations bolster Regeneron's R&D, presenting both opportunities and financial ...

Every hero has an origin story. For Atreya Manaswi, it started a few summers ago. He was out on a lake with a friend and his grandfather, a beekeeper. The older man was describing the dramatic ...

Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver, the companies ...

Regeneron is joining its pharma peers in the venture investing sector, committing up to $500 million over the next five years for its new private financing arm. The New York pharma unveiled ...

EAST GREENBUSH — Drugmaker Regeneron Pharmaceuticals, which employs more than 3,000 people in Rensselaer County, is being accused by the federal government of illegally inflating Medicare ...

George Yancopoulos is in touch with his teenage self. After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once ...

Thanks to an appeals court ruling, Regeneron has another chance to lay out its argument. The U.S. Court of Appeals for the Second Circuit has reversed (PDF) a lower court’s ruling to dismiss ...